MARKET

SPHDF

SPHDF

Santhera Pharmaceuticals Hldgs
EXMKT
22.85
NaN%
Closed 09:30 05/05 EDT
OPEN
--
PREV CLOSE
22.85
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
22.85
52 WEEK LOW
6.80
MARKET CAP
295.95M
P/E (TTM)
-3.3751
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at SPHDF last week (0427-0501)?
Weekly Report · 1d ago
Analyst Reiterates Buy on Santhera, Citing Leadership Transition and AGAMREE Momentum with Unchanged $30 Price Target
TipRanks · 04/27 10:26
Weekly Report: what happened at SPHDF last week (0420-0424)?
Weekly Report · 04/27 10:21
Santhera Receives Positive CHMP Opinion In Age Range Expansion For AGAMREE In Treating DMD
NASDAQ · 04/27 09:30
Santhera Moves Closer To Earlier Treatment Access For Young DMD Patients In Europe
NASDAQ · 04/27 08:11
Weekly Report: what happened at SPHDF last week (0413-0417)?
Weekly Report · 04/20 10:17
Weekly Report: what happened at SPHDF last week (0406-0410)?
Weekly Report · 04/13 10:21
Santhera: Advancing AGAMREE Reimbursement and European Uptake Underpins Reiterated Buy and CHF30 Target
TipRanks · 04/08 10:16
More
About SPHDF
Santhera Pharmaceuticals Holding AG (Santhera) is a Switzerland-based company engaged in the pharmaceutical sector. The Company operates through one business segment, which is the research, development and commercialization of pharmaceutical products for the treatment of neuromuscular and mitochondrial diseases, such as Duchenne muscular dystrophy (DMD) and cystic fibrosis (CF). The Company focuses also on development of gene therapy for the treatment of LAMA2 (Laminin Subunit Alpha 2) deficient congenital muscular dystrophy (CMD). Santhera operates through its wholly owned subsidiaries: Santhera Pharmaceuticals (Schweiz) AG, Liestal, Santhera Pharmaceuticals (USA) Inc, Santhera Pharmaceuticals (Canada) Inc, Santhera Pharmaceutical (Deutschland) GmbH and Oy Santhera Pharmaceuticals (Finland) Ltd.

Webull offers Santhera Pharmaceuticals Holding AG stock information, including EXMKT: SPHDF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SPHDF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SPHDF stock methods without spending real money on the virtual paper trading platform.